CPBIO Holding Company Limited

HK$7.50As of Sun 8 Nov 2026, 12:00 UTC
HKEX:3839Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR 11.95%
Div yield —
ROE 8.87%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 4.06
PE TTM 9.916
TSR TTM 10.13%
Mkt cap HK$1.900B
ROIC 6.90%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$9.27
23.57%
131.65%
Hold 8|5|9|1|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.09
0.10
0.10
0.09
5.98%
14.56%
12.72%
3.31%
Revenue$M
220.2
214.1
219.6
219.4
4.98%
4.73%
5.61%
4.97%
Peers (US$242.4M)
Cap (US$)
PE
236.0M
6.126x
Capital
TTM
5Y
10Y
Leveragex
2.285
0.146
0.129
EBIT/Intx
2.641
0.694
0.545
Own earn%
113.00
83.87
97.42
Sh yield%
39.32
43.83
43.58
Owners
Insiders/Inst%
6.98
63.37
Short interest%
5.12
SBC / revenue%
4.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
13–21
$1 testx
0.7
Incr. ROIC%
20